Monday, March 28, 2022 10:59:55 AM
Crickets.
I truly felt that Peter O'Rouke had a target picked out, having been on the Board at Axim and most probably having seen a few potential targets to acquire when Axim chose Sapphire Biotechnologies. I believe that Sapphire might have been the best suited for Axim at that time, but that Peter thought there were other promising targets that Axim just didn't have the capital to acquire.
Hence the reason for creating the SPAC.
Its now just over 3 months since the SPAC first went public (12/21/21). Maybe we just need one of those repetitious number dates, like 03/30/22, lol?
I'm certain, if an announcement was going to be made earlier, that the Military actions in the Ukraine would have delayed that announcement, but those actions are less and less in the news at this time.
Sure would be nice to finish off March Madness with a pps pop, or even something in the early Spring for that matter (April/May).
Let's see where things go.
These opinions are my own and are not intended as investment advice. If you feel that my statements are "Pumping", Propaganda, or manipulative in any way, please refrain from trading and seek medical treatment immediately.
Recent NVAC News
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 03/11/2024 01:05:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 10:00:32 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 02/28/2024 02:34:46 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 01/29/2024 01:00:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/18/2024 09:00:10 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 01/16/2024 01:27:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/28/2023 10:10:08 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 12/11/2023 11:10:15 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 12/01/2023 10:24:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:00:35 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 10/06/2023 08:29:23 PM
- Form 425 - Prospectuses and communications, business combinations • Edgar (US Regulatory) • 09/13/2023 09:16:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/13/2023 09:16:05 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 09/12/2023 09:19:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 09:00:37 PM
- Form S-4/A - Registration of securities, business combinations: [Amend] • Edgar (US Regulatory) • 07/21/2023 08:07:21 PM
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM